SCHEMBL20207728

SCHEMBL20207728

Cc1c(-c2ccccc2)c(-c2ccccc2)n(C)c1C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 2/20 0.43
▸ LMNA P02545 4/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ GRIA2 P42262 1/20 0.37
▸ GRIA4 P48058 1/20 0.37
▸ PTGS1 P23219 1/20 0.37
▸ PTGS2 P35354 1/20 0.37
▸ PTGER1 P34995 1/20 0.37
▸ SMN1; SMN2 Q16637 3/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ HPGD P15428 1/20 0.36
▸ BCL2L1 Q07817 1/20 0.36
▸ KMT2A Q03164 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ CDK8 P49336 1/20 0.35
▸ ACVR1 Q04771 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18701282 0.83 MAPT (0.39) MAPTLMNAALDH1A1GRIA2GRIA4
SCHEMBL18701271 0.83 ALDH1A1 (0.39) LMNAALDH1A1PTGER1NPC1RAB9A
SCHEMBL18701285 0.83 MAPT (0.41) MAPTLMNAGRIA2GRIA4PTGS1
SCHEMBL18701258 0.80 ALDH1A1 (0.42) MAPTLMNAALDH1A1PTGS2SMN1; SMN2
SCHEMBL12103427 0.75 ALDH1A1 (0.42) LMNAALDH1A1PTGER1NPC1RAB9A
SCHEMBL18701256 0.75 MAPT (0.45) MAPTLMNAALDH1A1GRIA2GRIA4
SCHEMBL19663897 0.73 GRIA4 (0.61) LMNAGRIA2GRIA4SMN1; SMN2KMT2A
SCHEMBL10949178 0.72 MAOB (0.44) MAPTALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL6294085 0.71 LMNA (0.48) MAPTLMNAALDH1A1PTGS1PTGS2
SCHEMBL8618279 0.71 LMNA (0.48) MAPTLMNAALDH1A1PTGS1PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180151807-A1 ORGANIC COMPOSITION AND ELECTRONIC DEVICE COMPRISING ORGANIC LAYER COMPRISING SAID COMPOSITION ROHM & HAAS ELECT MATERIALS KOREA LTD (KR) 2018-05-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180151807-A1 ORGANIC COMPOSITION AND ELECTRONIC DEVICE COMPRISING ORGANIC LAYER COMPRISING SAID COMPOSITION OR10J3, EPCAM, EPHA4 MAPT 751/4885LMNA 1352/4885ALDH1A1 1950/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback